PARATHYROID HORMONE (NatparĀ®)

Clinical Indication

Post-trial continuation of treatment of chronic hypoparathyroidism when standard therapy alone is inadequate.

Date of classification

November 2017

Review date

October 2019

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).